NCT04902040 2026-03-18
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
M.D. Anderson Cancer Center
Mayo Clinic
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Cancerologie de l'Ouest
Virginia Commonwealth University
University of Kentucky
Stanford University